Upgrade to SI Premium - Free Trial

Zymeworks (ZYME)

24.72 -0.38 (1.51%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (8/7/26 *Est.)

Latest Headlines

H.C. Wainwright Reiterates Buy Rating on Zymeworks (ZYME) June 3, 2026 6:52 AM - StreetInsider Form 4 Zymeworks Inc. For: May 13 Filed by: Schneider Paul R May 15, 2026 5:00 PM - SEC Filing Form 3 Zymeworks Inc. For: May 13 Filed by: Schneider Paul R May 15, 2026 4:55 PM - SEC Filing Form SCHEDULE 13G/A Zymeworks Inc. Filed by: Rubric Capital Management LP May 15, 2026 4:15 PM - SEC Filing Form 8-K Zymeworks Inc. For: May 14 May 14, 2026 4:30 PM - SEC Filing Zymeworks authorizes $125 million share repurchase program May 14, 2026 4:05 PM - StreetInsider Zymeworks Announces Share Repurchase Program of up to $125 Million of its Common Stock May 14, 2026 4:05 PM - StreetInsider Zymeworks Announces Participation in Upcoming Investor Conferences May 13, 2026 6:00 AM - StreetInsider Zymeworks (ZYME) Reiterated at Market Outperform by Citizens After Q1 Results May 11, 2026 4:19 AM - StreetInsider Zymeworks (ZYME) PT Raised to $34 at Wells Fargo May 8, 2026 6:55 AM - StreetInsider Zymeworks (ZYME) Misses Q1 EPS by 59c May 7, 2026 4:41 PM - StreetInsider Form 10-Q Zymeworks Inc. For: Mar 31 May 7, 2026 4:18 PM - SEC Filing Form 8-K Zymeworks Inc. For: May 07 May 7, 2026 4:13 PM - SEC Filing Zymeworks Provides Corporate Update and Reports First Quarter 2026 Financial Results May 7, 2026 4:06 PM - Globe NewsWire Zymeworks Provides Corporate Update and Reports First Quarter 2026 Financial Results May 7, 2026 4:05 PM - StreetInsider H.C. Wainwright Reiterates Buy Rating on Zymeworks (ZYME) April 28, 2026 6:43 AM - StreetInsider H.C. Wainwright Reiterates Buy Rating on Zymeworks (ZYME) April 23, 2026 6:59 AM - StreetInsider Zymeworks (ZYME) Reiterated at Buy by Stifel After AACR Presentation April 22, 2026 7:59 AM - StreetInsider Zymeworks reports positive phase 1 data for cancer drug ZW191 April 21, 2026 5:30 PM - StreetInsider Zymeworks Presents New Phase 1 Data for ZW191, a Folate Receptor Alpha-Targeting ADC at AACR Annual Meeting 2026 April 21, 2026 5:30 PM - StreetInsider Zymeworks presents preclinical data on RAS-targeting drug conjugates April 17, 2026 3:00 PM - StreetInsider Zymeworks Presents New Preclinical Data at AACR 2026 Highlighting Broad Antibody-Drug Conjugate Programs Including Novel RAS-Targeting Platform April 17, 2026 3:00 PM - StreetInsider Zymeworks to Report First Quarter 2026 Financial Results and Host Conference Call on May 7, 2026 April 16, 2026 6:00 AM - Globe NewsWire Form SCHEDULE 13G Zymeworks Inc. Filed by: PERCEPTIVE ADVISORS LLC April 15, 2026 4:16 PM - SEC Filing Form 4 Zymeworks Inc. For: Apr 09 Filed by: Schayowitz Adam April 10, 2026 4:10 PM - SEC Filing Form 4 Zymeworks Inc. For: Apr 09 Filed by: Platshon Scott April 10, 2026 4:10 PM - SEC Filing Form 3 Zymeworks Inc. For: Apr 09 Filed by: Schayowitz Adam April 10, 2026 4:05 PM - SEC Filing Form 3 Zymeworks Inc. For: Apr 09 Filed by: Platshon Scott April 10, 2026 4:05 PM - SEC Filing H.C. Wainwright Reiterates Buy Rating on Zymeworks (ZYME) April 10, 2026 6:45 AM - StreetInsider Zymeworks names new R&D head and chief business officer April 9, 2026 6:01 AM - StreetInsider Zymeworks Announces Additional Leadership Appointments to Advance Next Phase of Growth April 9, 2026 6:00 AM - Globe NewsWire Form 4 Zymeworks Inc. For: Apr 06 Filed by: Stafford Kristin April 7, 2026 3:03 PM - SEC Filing Form 3 Zymeworks Inc. For: Apr 01 Filed by: Stafford Kristin April 7, 2026 2:59 PM - SEC Filing Form 8-K Zymeworks Inc. For: Mar 31 April 1, 2026 6:17 AM - SEC Filing Zymeworks names Kristin Stafford as CFO effective April 1 April 1, 2026 6:00 AM - StreetInsider Zymeworks Appoints Kristin Stafford as Chief Financial Officer April 1, 2026 6:00 AM - StreetInsider Zymeworks receives FDA fast track designation for ovarian cancer drug March 30, 2026 6:00 AM - StreetInsider Zymeworks Receives U.S. FDA Fast Track Designation for ZW191, an FRα-Targeting Antibody-Drug Conjugate March 30, 2026 6:00 AM - StreetInsider Zymeworks Announces Participation in Upcoming Investor Conferences March 24, 2026 6:00 AM - StreetInsider Zymeworks Announces Presentations for Ziihera® (zanidatamab-hrii) at 2026 AACR Annual Meeting March 18, 2026 7:46 AM - StreetInsider Zymeworks to present clinical data on cancer drug candidates at AACR March 17, 2026 5:02 PM - StreetInsider Zymeworks to Present Clinical and Preclinical Data on ADC Programs Including Novel RAS ADC Platform at AACR Annual Meeting March 17, 2026 5:02 PM - Globe NewsWire Full Article List